These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Physiology of fibrinolysis and thrombolytic agents]. Perego D; Pogliani EM Recenti Prog Med; 1990 Apr; 81(4):276-81. PubMed ID: 2198643 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
4. [Thrombolytics and their use]. Alessi MC; Juhan-Vague I Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996 [TBL] [Abstract][Full Text] [Related]
5. [Tissue plasminogen activator: mechanism of action and thrombolytic properties]. Páramo JA; Collen D Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389 [No Abstract] [Full Text] [Related]
6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O; Rijken DC; Collen D Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339 [TBL] [Abstract][Full Text] [Related]
7. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ; Francis CW Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]
8. Fibrinolytic agents: mechanisms of activity and pharmacology. Lijnen HR; Collen D Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491 [TBL] [Abstract][Full Text] [Related]
9. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Collen D Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468 [No Abstract] [Full Text] [Related]
10. [Thrombolytic treatment of deep venous thrombosis]. Martínez-Brotons F; Cairols MA Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512 [No Abstract] [Full Text] [Related]
11. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacological potentials for activating the fibrinolytic system]. Markwardt F Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126 [TBL] [Abstract][Full Text] [Related]
13. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes. Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659 [TBL] [Abstract][Full Text] [Related]
14. Use of thrombolytic agents. Sternberg P; Tripathi RC; Tripathi BJ N Engl J Med; 1980 Apr; 302(14):812. PubMed ID: 7354822 [No Abstract] [Full Text] [Related]